Chair, Department of Laboratory Medicine and Pathology

Chair, Department of Laboratory Medicine and Pathology (LMP)
University of Minnesota Medical School
Minneapolis, Minnesota

Position Description

The University of Minnesota Medical School invites applications for the role of Chair of the Department of Laboratory Medicine and Pathology (LMP). This prestigious position presents a unique opportunity for an accomplished leader to shape the future of LMP within one of the nation’s top academic health systems. The successful candidate will advance the department’s mission of excellence in patient care, research, and education while fostering innovation and upholding its legacy of clinical and academic achievement.

This is a transformational leadership opportunity within a research-intensive, land-grant academic health center that ranks among the nation’s top institutions in NIH funding and interdisciplinary innovation. The Chair will join a leadership team focused on expanding precision medicine, investing in immunology and cancer discovery, and elevating academic excellence across the University of Minnesota Medical School and M Health Fairview partnership.

Role & Responsibilities

The successful candidate will possess a strong vision for the future of LMP and the ability to translate that vision into a thriving department. As Chair, you will play a pivotal role in:

• Strategic Leadership: Develop and execute a visionary strategic plan that enhances the department’s clinical, research, and educational programs while aligning with the broader goals of the University of Minnesota Medical School and health system partners. The Chair will foster deeper integration across these missions—strengthening collaboration between research, clinical care, and training—to promote innovation, reduce operational silos, and elevate departmental impact.
• Faculty Development: Recruit, mentor, and retain exceptional faculty and staff, fostering a culture of collaboration, inclusion, and professional growth.
• Research Advancement: Oversee a robust and diverse research portfolio, promoting interdisciplinary collaboration and securing extramural funding to advance LMP science.
• Clinical Excellence: Guide the strategic growth of clinical programs, ensuring the delivery of cutting-edge, patient-centered care across all subspecialties.
• Education and Training: Champion the department’s educational mission by enhancing residency and fellowship programs, supporting innovative teaching methods, and preparing the next generation of pathology leaders.
• Financial and Operational Management: Manage departmental resources effectively, including budget oversight, philanthropic development, and resource allocation to support strategic priorities.
• External Engagement: Cultivate relationships with regional and national healthcare leaders, industry partners, and community stakeholders to expand the department’s influence and impact.

Required Qualifications

• Educational and Professional Credentials:
  • Doctor of Medicine (MD), or equivalent international medical degree.
  • Board certification in Anatomic and/or Clinical Pathology (AP, CP, or AP/CP) by the American Board of Pathology (or equivalent).
  • Eligible for an unrestricted medical license in the state of Minnesota.
  • Qualified for a faculty appointment at the rank of Professor at the University of Minnesota Medical School.
• Leadership Experience:
  • At least 10 years of progressive leadership experience in an academic medical setting, with a demonstrated record of advancing clinical, research, and educational excellence.
  • Demonstrated ability to lead multidisciplinary teams and inspire excellence across education, research, and clinical care.
• Academic Excellence:
  • Nationally and/or internationally recognized expertise in pathology, as evidenced by a distinguished record of scholarly contributions, including high-impact peer-reviewed publications.
• Skills and Competencies:
  • Exceptional leadership, interpersonal, and communication skills, with the ability to engage effectively with diverse audiences, including faculty, staff, students, patients, donors, and external stakeholders.
  • Proven ability to foster and sustain collaborative relationships across departments, institutions, and external partners.
  • Strong fiscal management skills, with experience overseeing complex budgets and allocating resources efficiently to support strategic priorities.
• Commitment to Mentorship and Inclusion:
  • Demonstrated commitment to mentoring and developing junior faculty and trainees, fostering career growth and academic achievement.
  • Commitment to promoting diversity, equity, and inclusion across research, education, and patient care domains.

Ideal Candidate Profile

The ideal candidate is a visionary and collaborative leader who:

• Brings an exceptional track record in academic pathology, including impactful research and innovative clinical program development.
• Possesses strong leadership experience in an academic medical center or health system with the ability to drive strategic growth and inspire faculty.
• Champions mentorship, faculty development, and diversity in the academic workplace.
• Demonstrates commitment to advancing diagnostic innovation, precision medicine, and interdisciplinary research.
• Understands the evolving landscape of laboratory medicine, including regulatory, financial, and operational dynamics in both academic and clinical settings.
• Exhibits a high level of intellectual curiosity, entrepreneurial mindset, and business acumen.
• Is a forward-thinking visionary committed to investing in and developing cutting-edge technologies that will shape the future of pathology and laboratory medicine.
• Demonstrates a strong record of impactful research with sustained extramural funding—ideally including NIH, NCI, or other federal support—and a clear vision for advancing the department’s national research stature.
• Brings experience in national leadership roles, such as participation in NIH study sections, research councils, or multi-institutional research consortia.
• Has a proven track record of developing and sustaining strong clinical programs, with the ability to articulate and implement a strategic vision that integrates clinical excellence with research and educational priorities.
• Distinguished management experience, with strong financial management and recruitment skills.

Why Join Us?

The Department of Laboratory Medicine and Pathology (LMP) at the University of Minnesota is distinguished by a remarkable legacy of excellence and continuity in leadership. Since its founding, the department has been led by just two chairs, with current Chair Dr. Leo Furcht serving in the role for over 35 years. Under his leadership, LMP has grown into a nationally respected academic powerhouse with a culture rooted in collegiality, innovation, and interdisciplinary collaboration.

LMP’s legacy includes a tradition of pioneering leadership in pathology—shaping subspecialty fields, advancing translational diagnostics, and contributing to landmark discoveries in immunology, cancer biology, and molecular medicine. For the next Chair, this is a rare opportunity to build upon a strong institutional foundation and lead one of the country’s most stable and forward-thinking pathology departments into its next era of scientific and clinical innovation.

The department’s resources include the Advanced Research and Diagnostics Laboratory (ARDL), a nationally recognized core facility supporting over 100 global trials across cardiovascular, metabolic, and neurological disease domains.

Department of Laboratory Medicine and Pathology (LMP)

The University of Minnesota Department of Laboratory Medicine and Pathology (LMP) has a distinguished legacy of excellence in patient care, research, and education. Through a culture rooted in collegiality, synergistic collaboration, and academic excellence, the department continues to advance the frontiers of medicine. Faculty are actively engaged in innovative research, delivering impactful educational experiences, and providing exceptional patient care. The department values the contributions of its faculty, trainees, staff, and patients in achieving excellence across all areas of its mission.

Key Features

Faculty: The department includes over 80 faculty members, many of whom are nationally and internationally recognized experts in a broad range of clinical subspecialties and research disciplines.

Residents: Sixteen residents are enrolled in a highly competitive and comprehensive ACGME-accredited training program.

Fellowship Programs: The department offers fellowship training in Blood Banking & Transfusion Medicine, Cell Therapy & Regenerative Medicine, Clinical Chemistry, Cytopathology, Gastrointestinal Pathology, Gynecologic & Breast Pathology, Hematopathology, Laboratory Genetics & Genomics, Molecular Genetic Pathology, Neuropathology, and Surgical Pathology.

Comprehensive Education: Educational opportunities span all stages of medical training, including medical student clerkships, summer internships, a post-sophomore fellowship program, residency and fellowship programs, and post-residency research experiences.

Clinical Subspecialties: The department demonstrates expertise across numerous clinical areas, including autopsy, breast pathology, cytopathology, dermatopathology, gastrointestinal pathology, gynecologic pathology, neuropathology, renal pathology, genitourinary pathology, head and neck pathology, liver transplant pathology, soft tissue and bone pathology, thoracic pathology, cell therapy, clinical chemistry, clinical informatics, coagulation, cytogenetics, hematopathology, clinical microbiology, molecular diagnostics, HLA/immunology, and transfusion medicine/blood banking.

The department also owns and operates M Physicians Outreach Laboratories, a clinical reference laboratory that specializes in innovative and complex diagnostic testing. This laboratory is regionally and nationally recognized and accredited by CLIA and the College of American Pathologists (CAP).

Research Excellence: LMP supports robust research programs with significant extramural funding, primarily focused on cancer, immunology, cardiovascular disease, diabetes, and genetics. The department’s anatomic and clinical pathology expertise makes it a trusted partner and tissue resource for research across the University of Minnesota. As of federal year 2024, the department ranks 12th out of 93 in the Blue Ridge Institute for Medical Research rankings, with $19.5 million in research funding.

The department also operates the Advanced Research & Diagnostics Laboratory (ARDL)—a central biochemistry laboratory offering state-of-the-art clinical laboratory and genomics testing services to academic and industry researchers. ARDL is accredited by CLIA, CAP, and the New York State Department of Health.

Education & Training Programs

The Department of Laboratory Medicine and Pathology (LMP) at the University of Minnesota Medical School is a comprehensive academic training environment that prepares future leaders in pathology and laboratory medicine through rigorous, multidisciplinary education. The department supports 16 residents across multiple training pathways (AP/CP, AP/NP, AP-only, CP-only), as well as 13 fellows across 11 ACGME- and non-ACGME-accredited fellowship programs including Transfusion Medicine, Clinical Chemistry, Molecular Genetic Pathology, Hematopathology, Neuropathology, GI Pathology, and more. LMP offers structured experiences in academic, community, and federal healthcare systems, supported by a diverse faculty and robust research opportunities. The department also provides extensive educational programming for medical students, including elective clerkships, a post-sophomore fellowship, and a competitive summer internship. With access to leading-edge laboratories, digital pathology platforms, and high-volume diagnostic services, LMP trainees are equipped with the clinical, scientific, and leadership skills to excel in both academic and community settings.

Residency Program

The Department of Laboratory Medicine and Pathology at the University of Minnesota Medical School offers a nationally respected residency training program, currently home to 16 residents. Known for its flexible structure, breadth of training sites, and individualized pathways, the program prepares graduates for successful careers in academic medicine, community practice, and physician-scientist roles.

Training Tracks

The department offers several training tracks:

• AP/CP Combined (4 years)
• AP/NP Combined (4 years)
• AP-only or CP-only (3 years)
• Residents in any track may apply to pursue an additional post-residency research year, with departmental funding available for qualified proposals. A Physician-Scientist Training Program is available for residents with a strong research interest and background, including those with MD/PhD training.

Residents benefit from over 30 faculty mentors and have access to world-class research in cancer biology, immunology, neuroscience, cardiovascular disease, renal pathology, diabetes, and infectious disease. Weekly didactics, unknown case conferences, tumor boards, and hands-on supervision ensure readiness for independent practice and board certification.

Training Sites

Residents rotate through a diverse set of affiliated hospitals and medical centers, gaining exposure to multiple pathology practice models:

• M Health Fairview University of Minnesota Medical Center
  A 743-bed academic hospital with nearly 30,000 surgical specimens, 3.7 million clinical pathology assays annually, and robust AP/CP services. 
• Abbott Northwestern Hospital (Allina Health)
  A 686-bed quaternary care center known for its private practice model, high subspecialty volume (94,000+ surgical cases annually), and leading breast and GYN/perinatal pathology services. 
• Hennepin County Medical Center
  A 473-bed Level I Trauma Center offering community-based pathology, forensic autopsies (1,200+ per year), cytology, and bone marrow evaluations. 
• Veterans Affairs Medical Center
  A 361-bed facility with a high volume of AP/CP services, including 14,600 surgical specimens, 3.4 million assays, and a commitment to veteran care and education. 
• Hennepin County Medical Examiner
  The Hennepin County medical examiners office provides death investigative services and forensic autopsy services for deaths that occur in Hennepin and Scott counties.

These rotations give residents exposure to academic, private, community, and federal healthcare systems, ensuring a well-rounded and versatile pathology education.

Curriculum & Research

Training includes core rotations in surgical pathology, autopsy, cytopathology, transfusion medicine, microbiology, hematopathology, molecular diagnostics, clinical chemistry, laboratory information technology and lab management. Residents also complete at least 30 autopsies, participate in Grand Rounds, and are encouraged to present original research at national meetings.

The program provides up to 6 months of research time during residency, with the option of a dedicated post-residency research year. Research mentorship spans across basic science and clinical faculty, fostering development in diagnostic innovation and translational science.

Fellowship Programs

The Department of Laboratory Medicine and Pathology offers a robust portfolio of ACGME-accredited and specialty fellowships designed to develop the next generation of subspecialty pathologists, laboratory directors, and translational researchers. Each program emphasizes diagnostic excellence, multidisciplinary collaboration, and career development tailored to both academic and community practice.

Fellows take on meaningful clinical responsibilities, gain hands-on experience in lab management, engage in case consultations with clinical colleagues, and contribute to resident and student education. All fellows are encouraged and supported to participate in scholarly activity, including national presentations and peer-reviewed publications.

The department currently offers fellowship training in the following subspecialty areas:

• Blood Banking & Transfusion Medicine – Comprehensive training across M Health Fairview, Memorial Blood Centers, American Red Cross, and the VA system, with additional exposure to cell therapy and coagulation labs.
• Cell Therapy & Regenerative Medicine – Focused on cell manufacturing, quality systems, and regulatory oversight for novel cellular therapies, including CAR-T and iPSC technologies.
• Clinical Chemistry – Accredited by the Commission on Accreditation in Clinical Chemistry (COMACC), offering rigorous training in lab medicine, patient care, and laboratory leadership.
• Cytopathology – Broad experience in gynecologic and non-gynecologic cytology, fine-needle aspiration, and interdepartmental diagnostics at both UMMC and Hennepin Healthcare.
• Gastrointestinal Pathology – High-volume fellowship emphasizing oncologic pathology, transplant medicine, and IBD, with integration of molecular diagnostics and cytopathology.
• Gynecologic & Breast Pathology – Subspecialty training in high-volume GYN and breast cases, supported by state-of-the-art ancillary testing and strong research mentorship.
• Hematopathology – Exposure to complex adult and pediatric hematologic disorders, bone marrow biopsies, and advanced flow cytometry, with significant involvement in transplant and leukemia/lymphoma cases.
• Laboratory Genetics & Genomics (LGG) – Training in cytogenetics and molecular genetics with a focus on precision testing, clinical consultation, and integration of genomic data into patient care.
• Molecular Genetic Pathology (MGP) – Advanced training in NGS, PCR-based diagnostics, and molecular oncology, designed to develop future leaders in molecular diagnostics and translational research.
• Neuropathology – Dual-track program with surgical and autopsy neuropathology, research training, and collaboration with neurology and forensic services.
• Surgical Pathology – High-volume, subspecialized experience in GU, GYN, breast, GI, thoracic, and soft tissue pathology. Includes digital pathology integration, quality assurance training, and mentorship for academic careers.

Each fellowship is led by nationally recognized faculty and tailored to ensure progressive responsibility, multidisciplinary engagement, and individualized academic development. Fellows are empowered to customize electives and pursue scholarly projects that align with their long-term goals.

Research

The Department of Laboratory Medicine and Pathology (LMP) is a nationally recognized leader in both basic and translational research. The department supports a vibrant and diverse portfolio of scientific inquiry, with research strengths spanning cancer biology, immunology, neuroscience, cardiovascular disease, metabolic disorders, infectious disease, molecular diagnostics, and genetics.

NIH Funding and National Ranking

LMP consistently ranks among the top 15 pathology departments in the U.S. in National Institutes of Health (NIH) research funding.

In federal fiscal year 2024, LMP ranked 12th out of 93 pathology departments nationally according to the Blue Ridge Institute for Medical Research, with $19.5 million in NIH research funding.

The department’s sustained success in securing competitive extramural funding reflects the strength and innovation of its faculty-led programs.

Commitment to Discovery and Innovation

The department fosters a strong research culture, encouraging early-stage investigators, offering protected time for research faculty, and promoting multidisciplinary team science. LMP faculty routinely publish in top-tier journals, serve on national study sections, and mentor the next generation of physician-scientists and research leaders.

Facilities and Collaborative Platforms

LMP researchers benefit from access to state-of-the-art facilities, including the ARDL, Masonic Cancer Center Shared Resources, the University’s Biomedical Discovery District, and cross-campus core laboratories in genomics, imaging, informatics, and proteomics.

The department also manages the University of Minnesota Physicians Outreach Laboratories, enabling clinical-translational research grounded in complex diagnostic innovation.

Advanced Research and Diagnostics Laboratory (ARDL)

The Advanced Research and Diagnostics Laboratory (ARDL) is a nationally recognized central biochemical laboratory within the Department of Laboratory Medicine and Pathology at the University of Minnesota. The laboratory occupies over 30,000 sq ft and employees over 50 laboratory staff and technologists. ARDL plays a pivotal role in advancing large-scale translational research by offering high-throughput, state-of-the-art clinical laboratory and genomic testing services. It serves as a critical infrastructure resource for academic and industry-sponsored studies, including some of the NIH’s largest multicenter, longitudinal trials in cardiovascular disease, diabetes, and metabolic health.

Accredited by CLIA, CAP, and the New York State Department of Health, ARDL supports over 100 active projects globally and has been instrumental in managing biorepositories, specimen processing, and advanced analytical assays. Its expertise in biomarker development and clinical trial laboratory management positions it as a premier research partner across the University and beyond. The incoming Chair will inherit the opportunity to strategically leverage ARDL’s resources to expand research capacity, industry collaborations, and cross-disciplinary innovation within and outside of LMP.

ARDL supports:

• NIH landmark studies such as MESA, Look AHEAD, SPRINT, EDIC and more
• Over 100 active clinical trials and biobanking projects
• Biospecimen processing and storage for high-volume initiatives

Molecular and Cellular Therapeutics (MCT) Laboratory

The Molecular and Cellular Therapeutics (MCT) facility, operated by the Department of Laboratory Medicine and Pathology (LMP), is a nationally recognized cGMP/cGTP-compliant manufacturing center at the University of Minnesota. The facility plays a critical role in translating experimental research into clinical applications by producing novel, investigational biological products—including cell-, gene-, tissue-based therapies, monoclonal antibodies, and other biologics—for Phase I and II clinical trials.

Housed within the University’s Academic Health Center, MCT combines state-of-the-art technical infrastructure with deep regulatory, quality, and development expertise to support academic investigators, biotechnology companies, and federal programs. The lab provides end-to-end services for therapeutic manufacturing, including process development, scale-up, validation, quality assurance, and compliance with FDA standards. These capabilities allow researchers to efficiently bridge the gap between discovery science and first-in-human studies.

MCT is also home to the Production Assistance for Cellular Therapies (PACT) program, a major NIH/NHLBI-funded initiative that supports the production and testing of novel cellular therapies at a national scale. Under the leadership of Dr. David McKenna, Professor of Laboratory Medicine and Pathology and MCT’s Scientific and Medical Director, the facility has been instrumental in advancing cellular therapies for conditions such as graft-versus-host disease and transplant tolerance, including pioneering work with T regulatory cells derived from cord blood.

In addition to its role in immunotherapy and regenerative medicine, MCT supports cutting-edge translational research partnerships across the University. Notable collaborations include the development of off-the-shelf biological blood vessels with the Department of Biomedical Engineering, underscoring MCT’s multidisciplinary impact.

For the incoming Chair of LMP, MCT represents a strategic and high-impact asset, offering unparalleled opportunities to lead and expand clinical-grade biotherapeutic innovation, enhance academic-industry partnerships, and foster translational research that brings laboratory discoveries directly to patients.

Research Programs & Strategic Affiliations

The Department of Laboratory Medicine and Pathology has both strong basic and clinical research components. It has consistently been ranked among the top pathology departments in the United States in National Institutes of Health (NIH) grant funding.

The department has been very effective in promoting these efforts by working in partnership with Medical School-wide centers. Through these partnerships, the department has strengthened its own research base while making major contributions to the research enterprise of the institution as a whole. The department is fundamentally committed to building on these productive interactions and promoting the research opportunities they afford. LMP faculty lead and participate in major research initiatives that include:

Cancer Biology & Precision Oncology

LMP maintains a deep and productive partnership with the Masonic Cancer Center, an NCI-designated Comprehensive Cancer Center. Many LMP faculty hold leadership roles in the center, including:

• Dr. Kaylee Schwertfeger: Co-Leader, Cellular Mechanisms Program
• Dr. Christopher Pennell: Associate Director, MCC Training and Education, Director, Flow Cytometry Shared Resource
• Dr. Michael Farrar: Co-Leader, Hematologic Malignancy Translational Working Group
• Dr. Yoji Shimizu: Co-leader, Immunology Program
• Dr. Scott Dehm: Co-Leader, Prostate and Urologic Cancer Translational Working Group
• Dr. Betsy Hirsch: Director, Cancer Genomics Shared Resource

LMP researchers lead investigations in tumor biology, tumor microenvironments, genitourinary cancers, cytogenomics, and molecular diagnostics, supported by significant extramural funding.

Immunology

The department has a long history of immunology research. In 1995, LMP department faculty established the Medical School-wide Center for Immunology (CFI), which is now one of the University’s most prestigious research centers. The CFI includes over 70 faculty members across the Medical School, College of Veterinary Medicine, and Department of Biomedical Engineering; of these, nine are primary faculty members of LMP, reflecting the department’s central role in advancing immunologic discovery.

LMP investigators conduct NIH-funded research in immune regulation, T-cell biology, transplant immunology, and cancer immunotherapy. Faculty also help lead the center’s scientific direction—most notably:

• Kristin Hogquist, Associate Director and a national expert in T-cell development
• Carla Rothlin (incoming Director, 2025), internationally recognized for her work on immune homeostasis and receptor tyrosine kinases

The department’s foundational contributions to the CFI and longstanding leadership in immunology research position it as a central force in advancing translational discovery, shaping national research agendas, and training the next generation of immunologists.

Cardiovascular, Renal Disease & Diabetes

Through the Advanced Research and Diagnostics Laboratory (ARDL), the department supports major NIH-funded studies in diabetes, lipid metabolism, and cardiovascular disease, serving as a central lab for global trials. ARDL is a distinguished central biochemical laboratory that manages routine and specialized clinical testing requests, including specimen procurement and sample storage for more than a hundred active projects worldwide. ARDL has served as the central lab for some of the National Institute of Health’s largest multi-center, longitudinal studies of cardiovascular disease and diabetes.

In addition, ARDL plays a growing role in neuroscience research. For example, the Grossman Center Brain Health and Aging Registry and Biorepository Initiative utilizes ARDL as its central repository site for human research sample processing and storage, reinforcing its critical value across multiple domains of translational science.

Neuroscience

The neuroscience group within the department utilizes a variety of cellular and genetic approaches, including the genomic engineering of laboratory animals, to examine mechanisms of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and ataxias. Department faculty members also work in the Medical School-wide Grossman Center for Memory Research and Care and the Institute for Translational Neuroscience, a presidential initiative to promote the transfer of discoveries in the basic neurosciences to clinical practice.  ITN is led by LMP Regents Professor and Kavli Prize winner, Harry Orr, PhD. 

Molecular Genetics & Genomic Medicine

The Department of Laboratory Medicine and Pathology operates a state-of-the-art Molecular Genetics Laboratory, central to its mission in both precision diagnostics and translational research. The lab is CLIA-certified and CAP-accredited, and it delivers high-complexity molecular testing across a broad spectrum of clinical areas, including inherited disorders, cancer genomics, infectious diseases, and pharmacogenomics.

The MGL integrates next-generation sequencing (NGS), PCR-based methods, cytogenetic analysis, and bioinformatics workflows—supporting both patient care and investigational research. Faculty in this area lead assay development, participate in national consortia, and mentor fellows and residents, including those in the department’s ACGME-accredited Molecular Genetic Pathology fellowship.

This infrastructure plays a foundational role in the department’s broader efforts in precision medicine, and offers extensive collaboration opportunities across the Masonic Cancer Center, Institute for Translational Neuroscience, and University-wide genomic and computational cores.

The next Chair will have the opportunity to strengthen this high-impact program by advancing research innovation, expanding clinical testing, and positioning LMP as a leader in genomic diagnostics.

AI & Digital Pathology:

The Department of Laboratory Medicine and Pathology has made significant, strategic investments in digital pathology and AI-integrated diagnostics. At the core of this effort is a high-throughput Hamamatsu NanoZoomer S360 whole slide scanner—one of the most advanced and fastest systems available, with 360-slide capacity, continuous loading, AI-driven scan quality control, and rapid 40x imaging. The scanner is fully integrated with Indica Labs’ HALO platform, including:

• HALO AP: a HIPAA-compliant system for clinical case management
• HALO AI: a toolset for building custom deep learning algorithms
• HALO Link: a platform for collaborative research and education

These tools are actively leveraged for consult archiving, tumor boards, trainee education, translational research, and AI-assisted image analytics. This digital ecosystem positions the department for national leadership in computational pathology and precision diagnostics.

The next Chair will have the opportunity to grow this platform, foster interdisciplinary partnerships, and drive innovation in an increasingly data-driven future for pathology.

Research Partners

Center for Immunology

The Center for Immunology (CFI) at the University of Minnesota is one of the institution’s most prominent interdisciplinary research hubs, with a mission to advance fundamental and translational immunology while training the next generation of immunologists. Founded in 1995 by faculty from the Department of Laboratory Medicine and Pathology (LMP), the CFI represents a cornerstone of immunological discovery within the Medical School.

Key Highlights:

• Multidisciplinary Integration: The CFI includes over 70 faculty members across the Medical School, College of Veterinary Medicine, and Department of Biomedical Engineering. Of this group, nine are primary faculty in LMP, demonstrating the department’s leadership within the center.
• Research Excellence: Investigators at the CFI conduct high-impact research in areas such as immune regulation, cancer immunology, autoimmunity, infectious diseases, and transplant immunology. Their work is supported by robust NIH and extramural funding.
• Collaborative Culture: CFI promotes an environment of intellectual exchange through weekly seminars, joint lab meetings, and cross-departmental collaborations. It serves as a collaborative bridge between basic scientists and clinician-researchers within LMP and beyond.
• World-Class Leadership: In August 2025, internationally renowned immunologist Carla Rothlin will join the University of Minnesota and assume leadership of the CFI. Dr. Rothlin will serve as Director of CFI, Co-Leader of the Masonic Cancer Center’s Immunology Program, Andersen Chair in Immunology, and Professor of Laboratory Medicine and Pathology. Her arrival marks a transformative moment for CFI and significantly strengthens LMP’s partnership with the center. Current LMP faculty, including Dr. Kristin Hogquist, continue to hold key leadership roles—Dr. Hogquist will remain as Associate Director of the Center.
• Shared Core Facilities and Infrastructure: Members of the CFI benefit from access to state-of-the-art core facilities, including flow cytometry, imaging, single-cell analysis, and computational biology.
• Education and Mentorship: The CFI is also a training powerhouse, supporting graduate students and postdoctoral fellows through NIH T32 training programs, summer internships, and departmental collaborations

For the incoming Chair of LMP, the CFI offers a strategic opportunity to lead or expand collaborative immunology initiatives, recruit top-tier faculty, and elevate the department’s national visibility in translational immunology research.

Masonic Cancer Center

The mission of the Masonic Cancer Center is to reduce cancer’s burden in Minnesota and throughout the world.

The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing discoveries with other scientists, students, professionals, and our community.

Founded in 1991, the cancer center became a National Cancer Institute (NCI) designated Comprehensive Cancer Center in 1998, one of only 57 institutions in the United States and two in Minnesota to hold that designation. Every five years, the cancer center applies to renew that designation via a competitive and rigorous process. It is part of the health sciences at the University of Minnesota, which includes the U of M Medical School, the Schools of Dentistry, Nursing, and Public Health, and the Colleges of Pharmacy and Veterinary Medicine. MCC’s research partners include the University’s Stem Cell Institute, Center for Immunology, Center for Magnetic Resonance Imaging, Clinical and Translational Science Center, and Physical Sciences in Oncology Center. MCC’s clinical research and treatment partners include University of Minnesota Medical Center and University of Minnesota Masonic Children’s Hospital.

The External Scientific Advisory Board, which consists of national experts in basic, clinical and population-based research, participates in an annual external scientific review of the Masonic Cancer Center’s activities.

Institute for Translational Neuroscience

The Institute for Translational Neuroscience (ITN) at the University of Minnesota is distinguished by its ability to unite diverse groups under a shared mission: advancing neuroscience research across the institution.

Established in 2007 as a university-wide presidential initiative, ITN was created to facilitate the translation of basic neuroscience discoveries into clinical applications. The institute is charged with enhancing basic science research to generate new knowledge that informs clinical trials and leads to the development of novel therapeutic strategies and tools.

The institute’s primary goal is to attract and recruit top-tier scientists whose work will drive the discoveries that lead to future cures. ITN serves as a model for interdisciplinary collaboration, bringing together individuals from multiple departments, centers, and disciplines to advance neurological disease research at the University of Minnesota. The institute fosters a vibrant community grounded in education, innovation, and discovery—recognizing that success is amplified in a collaborative, team-oriented environment.

Patient Care

The Department of Laboratory Medicine and Pathology (LMP) at the University of Minnesota plays a critical role in advancing patient care through high-quality diagnostic services, expert interpretation, and innovative approaches to pathology and laboratory medicine. LMP faculty provide clinical service across a comprehensive spectrum of anatomic and clinical pathology subspecialties, supporting the diagnosis and treatment of complex medical conditions.

LMP’s clinical activities are grounded in collaboration, innovation, and a commitment to excellence in patient outcomes. The department delivers state-of-the-art diagnostic expertise in partnership with M Health Fairview and University of Minnesota Physicians, integrating cutting-edge science and personalized medicine to serve patients across the region.

Anatomic Pathology (AP)

The Anatomic Pathology (AP) division is a core pillar of diagnostic medicine at the University of Minnesota, with clinical practice strengths in oncology, transplant pathology, and disease-specific subspecialty care. The division is organized into expert-led teams focused on each of the body’s organ systems—including breast, gastrointestinal, gynecologic, genitourinary, head and neck, thoracic, soft tissue, and dermatopathology—enabling highly specialized interpretation and multidisciplinary collaboration across M Health Fairview and affiliated hospitals.

AP faculty are actively engaged in translational research spanning cancer biology, transplant rejection, and inflammatory diseases, and collaborate closely with the Masonic Cancer Center and other research institutes. The division is also leading a major initiative to establish a state-of-the-art brain and tissue banking and biorepository for aging and neurodegenerative disorders, which will serve as a critical platform for discovery in Alzheimer’s disease, Parkinson’s disease, and related conditions.

Educationally, AP plays a vital role across the academic continuum—from teaching medical students and mentoring residents and fellows, to advancing continuing medical education for practicing physicians. The division’s integrated clinical, research, and teaching missions ensure that AP remains at the forefront of diagnostic excellence and academic innovation.

Clinical Pathology (CP)

The Clinical Pathology (CP) division at the University of Minnesota plays a central role in delivering comprehensive diagnostic laboratory services across the health system, integrating clinical excellence, research innovation, and medical education. The division provides expert medical direction and oversight for a wide range of specialized laboratories, including:

• Clinical chemistry and toxicology
• Hematopathology and coagulation
• Transfusion medicine and apheresis
• Clinical microbiology and infectious diseases diagnostics
• Molecular diagnostics and next-generation sequencing
• Cytogenetics and laboratory genomics
• HLA and immunology laboratories
• Cell therapy and regenerative medicine

Clinical Pathology faculty are deeply embedded in both hospital-based and outreach laboratory operations, ensuring quality assurance, regulatory compliance, and innovation in test development. The division’s work supports a vast patient population through University of Minnesota Medical Center, M Health Fairview, affiliated regional hospitals, and the M Physicians Outreach Laboratories network.

CP is also home to cutting-edge translational research initiatives in infectious disease surveillance, molecular diagnostics, pharmacogenomics, and precision medicine. Faculty routinely serve as co-investigators in large, interdisciplinary NIH- and industry-funded studies, collaborating with basic scientists and clinicians to bring bench discoveries to bedside application.

In education, the division is responsible for core training in the AP/CP residency program and ACGME-accredited clinical pathology fellowships, including Clinical Chemistry, Hematopathology, Transfusion Medicine, Molecular Genetic Pathology, and Laboratory Genetics & Genomics. Trainees gain extensive experience in lab operations, test interpretation, informatics, and quality management, preparing them for leadership roles in academic, industry, and healthcare settings.

With a strong culture of mentorship, a track record of innovation, and critical contributions to healthcare delivery across Minnesota and beyond, the Clinical Pathology division is a cornerstone of the department’s tripartite mission and offers the incoming Chair strategic opportunities to expand its academic and operational impact.

M Physicians Outreach Laboratories

This network offers sophisticated diagnostic testing with expert interpretation, serving both local and regional healthcare providers through advanced laboratory capabilities and collaborative clinical leadership.

Extraordinary Pathology

University of Minnesota Physicians Outreach Laboratories is recognized for its expertise in innovative and complex diagnostic laboratory testing. With clinical and interpretive medical direction provided by pathologists, doctoral scientists, and other physicians, the laboratories are committed to delivering the highest quality results. While the technical laboratory services are performed by the University of Minnesota Medical Center, medical direction is provided by the department’s expert team.

Laboratory Research and Quality Assurance

Renowned both regionally and nationally, the laboratory offers a comprehensive range of testing services—from acute care support to highly specialized reference diagnostic testing. Each laboratory maintains a robust quality assurance program, which includes CAP Proficiency Testing and CAP Laboratory Inspection. The laboratories are accredited by the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP).

University of Minnesota

The University of Minnesota, founded in 1851, is one of the most comprehensive and prestigious public research universities in the United States. With its flagship Twin Cities campus boasting over 50,000 students, it ranks as the sixth-largest campus student body in the nation. The university offers an impressive array of academic programs, including more than 150 bachelor’s degrees, 200 master’s degrees, and 100 doctoral degrees across 19 colleges and schools.

As a leader in research and innovation, the University of Minnesota Medical School has made significant strides in recent years. In 2023, it ranked number 24 among all medical schools for National Institutes of Health funding, securing over $295M NIH awards. This achievement underscores the institution’s commitment to advancing medical discovery and improving healthcare outcomes. The Medical School’s research prowess is further evidenced by its ranking among the top three public research universities nationally, with more than 30 programs placing in the top 10 nationwide.

The Twin Cities campus offers an exceptional environment for both professional growth and quality of life. Minneapolis-St. Paul is home to 17 Fortune 500 companies, providing ample opportunities for collaboration and innovation. The area has been recognized for its livability, ranking highly in various metrics including literacy, entrepreneurship, and health. With a vibrant cultural scene featuring 130 art galleries, 35 museums, and all four major professional sports leagues, the Twin Cities offer a perfect balance of academic excellence and urban amenities.

University of Minnesota Medical School

Founded in 1888, the University of Minnesota Medical School draws on over 135 years of improving medicine through education, scientific discovery, and giving patients innovative and compassionate care. The University of Minnesota Medical School is a world-class institution committed to innovation, diversity, and excellence in medical education, research, and patient care. The school offers:

• Academic Health: The Medical School is part of one of the premier academic health centers in the country. The University of Minnesota is the only school in the nation to have schools of medicine, dentistry, pharmacy, nursing, public health, and veterinary medicine all on one campus.
• Nationally Recognized Research: Our medical school is revered as a national research powerhouse, with more than 10 research centers and institutes. We have long been recognized for its pioneering and are a worldwide leader in family medicine, regenerative medicine, transplantation, global medicine, and basic science research.
• Our Dean: Jakub Tolar, MD, PhD, is the Dean of the University of Minnesota Medical School and a Distinguished McKnight Professor in the Department of Pediatrics, Blood and Marrow Transplantation. He is also the Vice President of Clinical Affairs at the University of Minnesota, Board Chair for the University of Minnesota Physicians, and co-leader of M Health Fairview
• Research: At the University of Minnesota Medical School, we’re leading the way to new treatments and methods of care. Our research serves as an economic engine that drives Minnesota’s health industry. We develop new health technologies, and we collaborate with Minnesota’s biomedical companies to bring these technologies to clinics and hospitals worldwide. We are finding better and faster ways to translate our laboratory research into clinical trials for patients—the only path to new treatments and cures.
• UMP University of Minnesota Physicians: For more than two decades, the University of Minnesota Physicians (M Physicians) has served as the multi-specialty group practice for the University of Minnesota Medical School faculty. The organization supports the land grant mission of the University by delivering high-quality, innovative, and leading-edge care to patients across Minnesota and beyond. M Physicians is home to world-leading experts in a wide range of specialties and primary care. The organization is dedicated to the discovery of cures and treatments and offers patients access to the latest evidence-based care. University of Minnesota Physicians owns and operates specialty and family medicine clinics, employs more than 1,200 physicians and 2,400 providers and staff, and contributes a significant portion of operating revenue to support the University of Minnesota Medical School’s research and education priorities.

Twin Cities: Minneapolis and St. Paul

The Twin Cities, comprising Minneapolis and St. Paul, offer a vibrant and dynamic environment that is both an economic powerhouse and a cultural hub. With a combined population of nearly 3 million, the metropolitan area is home to 17 Fortune 500 companies, including industry leaders such as 3M, Target, and UnitedHealth Group. This strong economic foundation is complemented by a highly educated workforce and one of the lowest unemployment rates among large metro areas in the country. The region is consistently recognized for its quality of life, with U.S. News & World Report ranking Minnesota as the fifth best state for opportunity, natural environment, infrastructure, economy, and health care.

Beyond its economic strengths, the Twin Cities boast an exceptional cultural scene that attracts creative professionals and families alike. The area is renowned for its diverse arts and music offerings, featuring numerous theaters, museums, and galleries. Outdoor enthusiasts will appreciate the extensive parks and trails system, which includes over 340 miles of interconnected trails and 52 regional parks that welcome more than 47 million visitors annually. The Twin Cities also offer a rich culinary landscape with award-winning restaurants and food trucks, making it a delightful place for food lovers. Whether enjoying professional sports or exploring local festivals, residents find ample opportunities for recreation and community engagement throughout the year.

• The population of the Twin Cities metropolitan area is currently over 3.2 million people
• The Twin Cities offer an exceptional quality of life, combining urban amenities with natural beauty:
• Thriving economic center with 17 Fortune 500 companies
• Consistently ranked among the nation’s most livable cities
• Extensive parks, lakes, and trail systems
• Vibrant arts and culture scene, including world-class museums and theatres
• Excellent public transportation, including light rail connecting downtown areas
• Diverse and welcoming communities
• Four distinct seasons with year-round outdoor activities

Fortune 500 Companies in MSP
Minneapolis proper contains the 5th highest concentration of Fortune 500 companies in the country. The presence of the corporate headquarters for companies such as Target, US Bancorp, Xcel Energy and Ameriprise Financial provide a growing economy with great job opportunities for a candidate’s spouse or family.

Arts & Culture
Additionally, an exciting arts and music scene, exceptional shopping, award-winning restaurants, wineries and craft breweries, and distinctive accommodations can be found throughout the area. Outdoor enthusiasts find plenty to do – even when temperatures dip, the variety of fun outdoor adventures does not. Sports fans cheer on their favorite team year-round. Big city bustle or small-town charm, anyone can find the activity that suits them in the Minneapolis-Saint Paul Area.

Minneapolis-Saint Paul is a metropolitan area in the heart of the Midwest, and the largest city in the state of Minnesota. It offers a high quality of life, excellent public schools, and a strong economy, consistently ranking as one of the best places to live in the United States. The area boasts a thriving arts and culture scene, with world-class museums, theaters, and music venues, as well as extensive park systems, lakes, and trails for outdoor enthusiasts.

Hub for Medical Innovation & Research
Minneapolis-Saint Paul is recognized as a hub for medical innovation and research, with numerous healthcare organizations, including the world-renowned University of Minnesota Medical School, located in the region. Despite its many amenities, the area has a relatively low cost of living compared to other major metropolitan areas in the United States.

Twin Cities – A Rich History
The Twin Cities also have a rich history of diversity and inclusion, and the University of Minnesota is committed to fostering a welcoming and inclusive community. Additionally, Minneapolis-Saint Paul has a well-developed transportation system, including a light rail system, bus network, and extensive bike paths, making it easy to get around without a car. Overall, Minneapolis-Saint Paul offers a unique blend of urban sophistication, natural beauty, and cultural diversity that make it an attractive location for professionals in a variety of fields, including medicine and healthcare.

How to Apply

The University of Minnesota Medical School has retained the services of Academic Med, a national executive search firm that specializes in Academic Medicine, to assist with this strategically important search. The search for this esteemed position is being conducted by Gentry Zacheis, President & CEO of Academic Med & Jim Hagood, Managing Principal & Co-Founder of Academic Med. All inquiries, nominations, and applications will be handled with confidentiality.

Interested candidates should submit their curriculum vitae and a cover letter to:

• Jim Hagood, Managing Principal of Academic Med: ji*@**********ed.com
• Gentry Zacheis, President & CEO of Academic Med: ge****@**********ed.com

Application Deadline

The position will be open for applications until 5:00 PM CST on August 22, 2025. Applications received after this date will not be considered by the Search Committee.

Compensation & Benefits

Equal Opportunity Employer
The University of Minnesota is an equal opportunity educator and employer. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, sex, age, marital status, disability, public assistance status, veteran status, or sexual orientation.